TORPIANO, P. and PACE, D., 2018. Clinically-diagnosed Mediterranean Spotted Fever in Malta. Travel medicine and infectious disease, .
CAMILLERI, K. and PACE, D., 2017. Zika virus–the 21st century traveller. Malta Medical Journal, 21(01), pp. 1-4.
DHILLON, S. and PACE, D., 2017. Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review. Drugs, 77(17), pp. 1881-1896.
PACE, D., KHATAMI, A., ATTARD-MONTALTO, S., VOYSEY, M., FINN, A., FAUST, S.N., HEATH, P.T., BORROW, R., SNAPE, M.D. and POLLARD, A.J., 2016. Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy. Vaccine, 34(50), pp. 6350-6357.
BRÖKER, M., EMONET, S., FAZIO, C., JACOBSSON, S., KOLIOU, M., KUUSI, M., PACE, D., PARAGI, M., PYSIK, A. and SIMÕES, M.J., 2015. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013. Human vaccines & immunotherapeutics, 11(9), pp. 2281-2286.
IRO, M.A., KHATAMI, A., MARSHALL, A.S., PACE, D., VOYSEY, M., MCKENNA, J., CAMPBELL, D., ATTARD-MONTALTO, S., FINN, A. and WHITE, C., 2015. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial. The Lancet Infectious Diseases, 15(2), pp. 172-180.
PACE, D., KHATAMI, A., MCKENNA, J., CAMPBELL, D., ATTARD-MONTALTO, S., BIRKS, J., VOYSEY, M., WHITE, C., FINN, A., MACLOED, E., FAUST, S.N., KENT, A.L., HEATH, P.T., BORROW, R., SNAPE, M.D. and POLLARD, A.J., 2015. Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial. BMJ (Clinical research ed.), 350, pp. h1554.
TORPIANO, P. and PACE, D., 2015. Leishmaniasis: diagnostic issues in Europe. Expert review of anti-infective therapy, 13(9), pp. 1123-1138.
VELLA, M. and PACE, D., 2015. Glycoconjugate vaccines: an update. Expert opinion on biological therapy, 15(4), pp. 529-546.
KHATAMI, A., CLUTTERBUCK, E.A., THOMPSON, A.J., MCKENNA, J.A., PACE, D., BIRKS, J., SNAPE, M.D. and POLLARD, A.J., 2014. Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines–exploratory analyses within a randomised controlled trial. PloS one, 9(7), pp. e101672.
PACE, D., 2014. Leishmaniasis. J. Infect, 69(Suppl. 1), pp. 10-8.
TORPIANO, P. and PACE, D., 2014. Ebola: too far or so close? 26(03), pp. 32-40.
PACE, D., 2013. Glycoconjugate vaccines. Expert opinion on biological therapy, 13(1), pp. 11-33.
BRÖKER, M., JACOBSSON, S., DETORA, L., PACE, D. and TAHA, M., 2012. Increase of meningococcal serogroup Y cases in Europe: a reason for concern? Human vaccines & immunotherapeutics, 8(5), pp. 685-688.
BRÖKER, M., JACOBSSON, S., KUUSI, M., PACE, D., SIMÕES, M.J., SKOCZYNSKA, A., TAHA, M., TOROPAINEN, M. and TZANAKAKI, G., 2012. Meningococcal serogroup Y emergence in Europe: update 2011. Human vaccines & immunotherapeutics, 8(12), pp. 1907-1911.
PACE, D. and POLLARD, A.J., 2012. Meningococcal disease: clinical presentation and sequelae. Vaccine, 30, pp. B3-B9.
PACE, D., WILLIAMS, T.N., GROCHOWSKA, A., BETTS, A., ATTARD-MONTALTO, S., BOFFA, M.J. and VELLA, C., 2011. Manifestations of paediatric Leishmania infantum infections in Malta. Travel medicine and infectious disease, 9(1), pp. 37-46.
PACE, D., 2010. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults. Future microbiology, 5(11), pp. 1629-1640.
PACE, D., 2010. Vaccine prevention of meningococcal disease in adolescents and travelers. International Health, 2(4), pp. 229-230.
PACE, D., 2009. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Expert review of vaccines, 8(5), pp. 529-542.
PACE, D., POLLARD, A.J. and MESSONIER, N.E., 2009. Quadrivalent meningococcal conjugate vaccines. Vaccine, 27, pp. B30-B41.
PACE, D., 2009. MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection. Current opinion in molecular therapeutics, 11(6), pp. 692-706.
PACE, D., CUSCHIERI, P., DEBONO, A.G. and ATTARD-MONTALTO, S., 2008. Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: Implications for introducing PorA based vaccines. Vaccine, 26(47), pp. 5952-5956.
PACE, D., SNAPE, M., WESTCAR, S., OLUWALANA, C., YU, L.M., BEGG, N., WYSOCKI, J., CZAJKA, H., MAECHLER, G., BOUTRIAU, D. and POLLARD, A.J., 2008. A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial. Archives of Disease in Childhood, 93(11), pp. 963-970.
SNAPE, M.D., PERRETT, K.P., FORD, K.J., JOHN, T.M., PACE, D., YU, L., LANGLEY, J.M., MCNEIL, S., DULL, P.M. and CEDDIA, F., 2008. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. Jama, 299(2), pp. 173-184.
PACE, D. and POLLARD, A.J., 2007. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Archives of Disease in Childhood, 92(10), pp. 909-915.
PACE, D., SNAPE, M., WESTCAR, S., HAMALUBA, M., YU, L.M., BEGG, N., WYSOCKI, J., CZAJKA, H., MAECHLER, G., BOUTRIAU, D. and POLLARD, A.J., 2007. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants. The Pediatric infectious disease journal, 26(11), pp. 1057-1059.